Exelon (NASDAQ:EXC – Get Rating) was upgraded by research analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a note issued to investors on Wednesday, The Fly reports. The brokerage currently has a $55.00 target price on the stock, up from their prior target price of $47.00. JPMorgan Chase & Co.‘s target price would indicate a potential upside of 11.11% from the stock’s previous close.
Several other research firms also recently commented on EXC. Zacks Investment Research upgraded Exelon from a “sell” rating to a “hold” rating and set a $53.00 target price for the company in a research report on Tuesday, April 12th. Barclays started coverage on Exelon in a research report on Monday, February 7th. They issued an “equal weight” rating and a $46.00 target price for the company. BMO Capital Markets dropped their target price on Exelon from $63.00 to $47.00 in a research report on Thursday, February 17th. Morgan Stanley increased their target price on Exelon from $47.00 to $50.00 and gave the company an “overweight” rating in a research report on Tuesday, March 22nd. Finally, Vertical Research downgraded Exelon from a “buy” rating to a “hold” rating and set a $45.00 target price for the company. in a research report on Thursday, February 3rd. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $47.67.
NASDAQ:EXC opened at $49.50 on Wednesday. The stock’s 50-day simple moving average is $44.77 and its 200 day simple moving average is $50.23. The firm has a market capitalization of $48.52 billion, a PE ratio of 28.45, a price-to-earnings-growth ratio of 3.49 and a beta of 0.59. The company has a quick ratio of 0.75, a current ratio of 0.87 and a debt-to-equity ratio of 1.03. Exelon has a twelve month low of $30.57 and a twelve month high of $50.29.
Large investors have recently made changes to their positions in the stock. Elmwood Wealth Management Inc. purchased a new position in shares of Exelon during the fourth quarter valued at approximately $30,000. Curi Wealth Management LLC bought a new stake in Exelon during the fourth quarter worth $33,000. Missouri Trust & Investment Co bought a new stake in Exelon during the fourth quarter worth $36,000. Citizens National Bank Trust Department bought a new stake in Exelon during the fourth quarter worth $38,000. Finally, EverSource Wealth Advisors LLC bought a new stake in Exelon during the fourth quarter worth $38,000. 79.73% of the stock is currently owned by institutional investors.
About Exelon (Get Rating)
Exelon Corporation, a utility services holding company, engages in the energy generation, delivery, and marketing businesses in the United States and Canada. It owns nuclear, fossil, wind, hydroelectric, biomass, and solar generating facilities. The company also sells electricity to wholesale and retail customers; and sells natural gas, renewable energy, and other energy-related products and services.
- Get a free copy of the StockNews.com research report on Exelon (EXC)
- Is Turning Point Therapeutics Stock at a Turning Point?
- Buy Haliburton On Post-Earnings Weakness
- Constellation Brands Stock is Launching Towards New Highs
- 3 Analyst Favorite Blue-Chip Stocks to Buy Now
- Does PNC Financial Stock Belong in Your Portfolio?
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.